Drug Shortage Report for APO-OXAPROZIN
Report ID | 411 |
Drug Identification Number | 02243661 |
Brand name | APO-OXAPROZIN |
Common or Proper name | OXAPROZIN |
Company Name | APOTEX INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | OXAPROZIN |
Strength(s) | 600MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 BTL |
ATC code | M01AE |
ATC description | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2012-03-23 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2017-10-05 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-03-10 | English | Compare |
v2 | 2017-03-10 | French | Compare |
Showing 1 to 2 of 2